SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-028009
Filing Date
2021-05-14
Accepted
2021-05-14 16:06:10
Documents
92
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q fmtx-10q_20210331.htm 10-Q 2762378
2 EX-31.1 fmtx-ex311_7.htm EX-31.1 15572
3 EX-31.2 fmtx-ex312_6.htm EX-31.2 15696
4 EX-32.1 fmtx-ex321_8.htm EX-32.1 8025
  Complete submission text file 0001564590-21-028009.txt   9797395

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT fmtx-20210331.xml EX-101.INS 2165737
6 XBRL TAXONOMY EXTENSION SCHEMA fmtx-20210331.xsd EX-101.SCH 76370
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE fmtx-20210331_cal.xml EX-101.CAL 59276
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fmtx-20210331_def.xml EX-101.DEF 252763
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE fmtx-20210331_lab.xml EX-101.LAB 512168
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fmtx-20210331_pre.xml EX-101.PRE 428909
Mailing Address 500 ARSENAL STREET SUITE 100 WATERTOWN MA 02472
Business Address 500 ARSENAL STREET SUITE 100 WATERTOWN MA 02472 617-679-1970
Forma Therapeutics Holdings, Inc. (Filer) CIK: 0001538927 (see all company filings)

IRS No.: 371657129 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39333 | Film No.: 21924559
SIC: 2836 Biological Products, (No Diagnostic Substances)